Pei-Jian Shao
Overview
Explore the profile of Pei-Jian Shao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang H, Lu L, Hu B, Li Y, Shao P
Chin Med J (Engl)
. 2013 Nov;
126(22):4270-6.
PMID: 24238511
Background: The prognosis of unresectable large hepatocellular carcinomas is poor. This study evaluated the efficacy and safety of sorafenib combined with transcatheter arterial chemoembolization and radiofrequency ablation in the treatment...
2.
Zhan M, Li Y, Hu B, Shao P, Meng Q, He X, et al.
Zhonghua Yi Xue Za Zhi
. 2013 Oct;
93(23):1830-2.
PMID: 24124720
Objective: To investigate the abnormal expression of microRNAs (miR-216, miR-222, miR-181) in the serum of patients with hepatocellular carcinoma (HCC) and its clinical significance. Methods: Serum miRNAs expression was investigated...
3.
Meng Q, Li Y, Hu B, Shao P, Zhan M, Yu X, et al.
Zhonghua Yi Xue Za Zhi
. 2013 May;
93(5):341-4.
PMID: 23660204
Objective: To explore the prognostic significance of serum vascular endothelial growth factor receptor-2 (VEGFR-2) in patients with hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE). Methods: A total of 69...
4.
Luo X, Lu L, Shao P, Hu B, Li Y, Yu X, et al.
Zhonghua Yi Xue Za Zhi
. 2012 Jul;
92(13):889-93.
PMID: 22781529
Objective: To investigate the link between the antitumor efficacy of sorafenib and its cutaneous side effects in advanced hepatocellular carcinoma (HCC). Methods: We retrospectively analyzed the incidence of hand-foot skin...
5.
Li Y, Huang J, Lu L, Shao P, Hu B, Huang G, et al.
Zhonghua Yi Xue Za Zhi
. 2010 Oct;
90(31):2187-92.
PMID: 21029658
Objective: To provide more evidence sources to the standard treatment for patients with advanced hepatocellular carcinoma, the writer analyze patients' time to progression (TTP) and overall survival (OS) after patients...
6.
Zhou Z, Xu R, Li W, Zhuang W, Lu L, Shao P, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2007 Dec;
27(12):1866-8.
PMID: 18159005
Objective: To evaluate the therapeutic effects and adverse effects of transarterial oily chemoembolization combined with interstitial laser thermotherapy (TOCE+ILT) in the treatment of hepatocellular carcinoma. Methods: Totally 120 patients with...
7.
Chen X, Luo P, Lin H, Zhou Z, Shao P, Fu L, et al.
Ai Zheng
. 2004 Jul;
23(7):829-32.
PMID: 15248922
Background & Objective: Both transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) are the most important and popular procedures of interventional treatment for hepatocellular carcinoma (HCC). Although the improvement...